Review Article

Peripheral ulcerative keratitis: A review of aetiology and management

Roland Hӧllhumer
African Vision and Eye Health | Vol 81, No 1 | a697 | DOI: https://doi.org/10.4102/aveh.v81i1.697 | © 2022 Roland Hollhumer | This work is licensed under CC Attribution 4.0
Submitted: 02 August 2021 | Published: 13 January 2022

About the author(s)

Roland Hӧllhumer, Department of Neurosciences, Faculty of Ophthalmology, University of the Witwatersrand, Johannesburg, South Africa

Abstract

Background: Peripheral ulcerative keratitis (PUK) is a severe inflammatory disease of the peripheral cornea that can be caused by local factors or systemic inflammatory disease.

Aim: The purpose of this review is to give an overview of the pathophysiology, aetiology, clinical features, diagnosis, and management of PUK.

Method: A PubMed search was conducted using the keywords, ‘peripheral ulcerative keratitis’ and ‘Mooren’s ulcer’.

Results: The peripheral cornea has unique characteristics the predispose to the development of PUK. These include fine capillary arcades that allow for deposition of immune complexes and subsequent activation of an inflammatory cascade with corneal melt. Several conditions have been implicated in the aetiology of PUK. The most commonly cited causes are rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA) and various dermatoses. In patients with RA, PUK usually presents in established disease, whereas in GPA, PUK may be the presenting feature in up to 60% of cases. In RA it heralds the onset of a systemic vasculitis with significant associated morbidity and mortality. The management of PUK follows an individualised stepwise approach. All patients require supportive measures to encourage healing and halt the process of keratolysis. Systemic autoimmune conditions need a systemic corticosteroid as a fast-acting agent to halt the inflammatory process while cytotoxic therapy maintains long term disease control. Failure to achieve disease control with CTT, necessitates the use of a biologic agent.

Conclusion: Peripheral ulcerative keratitis is a severe inflammatory disease of the peripheral cornea that needs a thorough diagnostic workup and stepwise management approach.


Keywords

peripheral ulcerative keratitis; immunosuppression; cytotoxic therapy; biologic therapy; rheumatoid arthritis; granulomatosis with polyangiitis

Metrics

Total abstract views: 5723
Total article views: 9960

 

Crossref Citations

1. Peripheral ulcerative keratitis: Challenges in immunosuppressing an immunocompromised patient
Jacobus F. Heukelman, Craig D. Anderson
African Vision and Eye Health  vol: 84  issue: 1  year: 2025  
doi: 10.4102/AVEH.v84i1.1078

2. Pyoderma gangrenosum, peripheral ulcerative keratitis, and oral ulcers in a patient with inflammatory bowel disease
Amanda T. Chung, Roy Luister C. Acos, John Paulo L. Recio, Giselle Marie S. Tioleco-Ver, Belen L. Dofitas
JAAD Case Reports  vol: 61  first page: 78  year: 2025  
doi: 10.1016/j.jdcr.2025.04.013

3. Demographic Characteristics, Clinical Presentations, and Risk Factors Impacting Visual Outcomes in Peripheral Ulcerative Keratitis
Rohan Bir Singh, Sarah Atta, Divya Srikumaran, Vishal Jhanji
Cornea  vol: 43  issue: 12  first page: 1528  year: 2024  
doi: 10.1097/ICO.0000000000003541

4. Tenon’s patch grafting: An inexpensive technique for managing corneal perforation and descemetocele - Our experience of 12 months post-operative follow-up
Shefali Mazumdar, Rajendra P Maurya, Alok Gangwar, Jatin Kumar Singh, Adeeba Wahab, Arpit Gupta, Siddhartha Gupta
Indian Journal of Clinical and Experimental Ophthalmology  vol: 10  issue: 2  first page: 221  year: 2024  
doi: 10.18231/j.ijceo.2024.041